For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.
Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.
Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.
Shares of major healthcare companies Humana (NYSE: NYSE:HUM), CVS Health (NYSE: NYSE:CVS), Elevance Health, and Cigna (NYSE:CI) fell sharply in Friday's trading session, following a broader industry ...
The justice department is examining how the insurer’s methods of recording patient diagnoses could result in excess payments to UnitedHealth’s Medicare Advantage plans, a privately run offshoot of the ...
The investigation is evaluating Medicare billing protocols, according to the report.UnitedHealth shares sank after The Wall ...
Elevance Health, Inc. ( NYSE:ELV ) received a lot of attention from a substantial price movement on the NYSE over ...
The primary driver behind last 12 months revenue was the Health Benefits segment contributing a total revenue of US$150.3b (85% of total revenue). Notably, cost of sales worth US$127.6b amounted to 72 ...
Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...
Elevance Health Stock Down 1.7 % Shares of NYSE:ELV opened at $382.46 on Wednesday. The firm has a market cap of $88.70 billion, a P/E ratio of 14.93, a P/E/G ratio of 1.17 and a beta of 0.83 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results